Washington/Sputnik: A US Centers for Disease Control and Prevention (CDC) committee voted to give healthcare workers and nursing home residents the first of the COVID-19 vaccines once the ...
Washington: A COVID-19 vaccine, which is jointly developed by Pfizer and BioNTech, has shown 90 percent effectiveness in preventing Covid-19 infections during the ongoing Phase 3 trials, ...
Moscow/Sputnik: Any safe and effective vaccine against COVID-19 may not need to be administered annually, unlike vaccines for influenza, Dr. Richard Mihigo, the program area manager for i ...
Moscow/Sputnik: Millions of people in the United States may have to pay for COVID-19 vaccination contrary to the plans of the authorities to make the shots free, as government-funde ...
New York: UN Children’s Fund (UNICEF) will be leading procurement and supply of COVID-19 vaccinations to ensure that all countries have safe, fast and equitable access to initial do ...
Washignton: Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is ef ...
Moscow/Sputnik: Clinical trials of Russia's coronavirus vaccine developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology jointly with the Russian Defen ...
Boston: A Coronavirus vaccine developed by biotechnology company Moderna showed positive response in phase 1 study.
Washington/Sputnik: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.
- COVID-19 vaccine shipments boost for Africa
- Bhutan now has surplus vaccines; US sends 500,000 Moderna vaccines doses
- Equitable distribution of vaccines, equipment only way out of pandemic: WHO chief
- COVID-19: First mRNA vaccine tech transfer hub a 'great step forward'
- Johnson and Johnson’s single-dose vaccine approved in Bangladesh
